Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Vickie Young Jo, M.D.

Co-Author

This page shows the publications co-authored by Vickie Jo and Jeffrey Mito.
Connection Strength

2.880
  1. Mito JK, Bishop JA, Sadow PM, Stelow EB, Faquin WC, Mills SE, Krane JF, French CA, Fletcher CDM, Hornick JL, Sholl LM, Jo VY. Immunohistochemical Detection and Molecular Characterization of IDH-mutant Sinonasal Undifferentiated Carcinomas. Am J Surg Pathol. 2018 08; 42(8):1067-1075.
    View in: PubMed
    Score: 0.862
  2. Mito JK, Qian X, Doyle LA, Hornick JL, Jo VY. Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens. Am J Clin Pathol. 2017 Aug 01; 148(2):179-189.
    View in: PubMed
    Score: 0.804
  3. Mito JK, Jo VY. BRAF V600E is not a consistent feature of myopericytoma. J Cutan Pathol. 2016 Dec; 43(12):1248-1249.
    View in: PubMed
    Score: 0.768
  4. Mito JK, Qian X, Jo VY, Doyle LA. MYC expression has limited utility in the distinction of undifferentiated radiation-associated sarcomas from sporadic sarcomas and sarcomatoid carcinoma. Histopathology. 2020 Jun 07.
    View in: PubMed
    Score: 0.245
  5. Mito JK, Jo VY, Chiosea SI, Dal Cin P, Krane JF. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma. Histopathology. 2017 Oct; 71(4):511-521.
    View in: PubMed
    Score: 0.200
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.